Leslie Gillum is a Neurology physician affiliated with Diablo Valley College. OpenAlex indexes 18 publications with 1,310 citations (h-index 12).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
575 Lennon Ln Ste 152
Walnut Creek, CA 945982443
Telephone
925-602-7060Provider last certified this registry record 13 Jul 2021.
Industry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- ABBVIE INC.Program year20251 payment
- ABBVIE INC.Program year202411 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
83.9%Aromatic Amino Acid Decarboxylation Inhibitor14.2%Carbidopa-Levodopa55%Rytary24%Carbidopa-Levodopa Er22%Part D<11 patientsOther antiepileptics12.5%Levetiracetam72%Lacosamide16%Levetiracetam Er12%Part D<11 patients+ 14 more classes in this area
Cardiovascular
9.5%Statin6%Atorvastatin Calcium53%Rosuvastatin Calcium31%Pravastatin Sodium16%Part D<11 patientsBeta blocker2.6%Propranolol Hcl Er53%Propranolol Hcl47%Part D<11 patients+ 1 more class in this area
Cancer & immunology
2.8%Pyrimidine Synthesis Inhibitor1%Aubagio100%Part D<11 patientsSphingosine 1-phosphate Receptor Modulator0.9%Fingolimod100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency
Science Translational Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”